S9313A Protein Expression Analysis of Breast Cancer Tissue Microarrays From Clinical Trial SWOG-9313
Completed
Conditions studied: Breast Cancer
In brief
RATIONALE: Studying the proteins expressed in tumor tissue samples in the laboratory from patients with cancer may help doctors learn more about biomarkers related to cancer. It may also help doctors predict how patients respond to treatment. PURPOSE: This laboratory study is looking at protein expression in predicting response to treatment using tumor tissue samples from women with stage I, stage II, or stage IIIA breast cancer treated on clinical trial SWOG-9313.
Key facts
- Study ID
- NCT00896727
- Run by
- SWOG Cancer Research Network
- People needed
- 2100
- Starts
- 2006-07-17
- Expected to finish
- 2009-04-02
- Last updated by the study team
- 2019-12-20
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Yale Cancer Center — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.